nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—Burning sensation—Ramipril—type 1 diabetes mellitus	0.0563	0.0886	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.0411	0.0646	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.035	0.055	CcSEcCtD
Trisalicylate-choline—Deafness—Ramipril—type 1 diabetes mellitus	0.0318	0.0499	CcSEcCtD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—HSD11B2—type 1 diabetes mellitus	0.0261	0.0759	CbGpPWpGaD
Trisalicylate-choline—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.0259	0.0408	CcSEcCtD
Trisalicylate-choline—Asthma—Ramipril—type 1 diabetes mellitus	0.0246	0.0386	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.0235	0.037	CcSEcCtD
Trisalicylate-choline—Weight increased—Ramipril—type 1 diabetes mellitus	0.0223	0.0351	CcSEcCtD
Trisalicylate-choline—Sweating—Ramipril—type 1 diabetes mellitus	0.021	0.033	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—HSD11B2—type 1 diabetes mellitus	0.0207	0.0602	CbGpPWpGaD
Trisalicylate-choline—Epistaxis—Ramipril—type 1 diabetes mellitus	0.0206	0.0325	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—ALB—type 1 diabetes mellitus	0.0198	1	CrCbGaD
Trisalicylate-choline—Hepatitis—Ramipril—type 1 diabetes mellitus	0.0197	0.0309	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.0186	0.0292	CcSEcCtD
Trisalicylate-choline—Tinnitus—Ramipril—type 1 diabetes mellitus	0.0183	0.0288	CcSEcCtD
Trisalicylate-choline—Flushing—Ramipril—type 1 diabetes mellitus	0.0182	0.0287	CcSEcCtD
Trisalicylate-choline—Erythema—Ramipril—type 1 diabetes mellitus	0.0171	0.0269	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.0168	0.0263	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—FGF21—type 1 diabetes mellitus	0.0154	0.0446	CbGpPWpGaD
Trisalicylate-choline—Confusional state—Ramipril—type 1 diabetes mellitus	0.0141	0.0221	CcSEcCtD
Trisalicylate-choline—Oedema—Ramipril—type 1 diabetes mellitus	0.014	0.0219	CcSEcCtD
Trisalicylate-choline—Shock—Ramipril—type 1 diabetes mellitus	0.0137	0.0216	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.0135	0.0212	CcSEcCtD
Trisalicylate-choline—Anorexia—Ramipril—type 1 diabetes mellitus	0.0133	0.0209	CcSEcCtD
Trisalicylate-choline—Hypotension—Ramipril—type 1 diabetes mellitus	0.013	0.0205	CcSEcCtD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NOS1—type 1 diabetes mellitus	0.013	0.0379	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—DDIT3—type 1 diabetes mellitus	0.0125	0.0363	CbGpPWpGaD
Trisalicylate-choline—Somnolence—Ramipril—type 1 diabetes mellitus	0.0124	0.0195	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.0123	0.0193	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.0121	0.0191	CcSEcCtD
Trisalicylate-choline—Constipation—Ramipril—type 1 diabetes mellitus	0.0119	0.0188	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.0115	0.0181	CcSEcCtD
Trisalicylate-choline—Urticaria—Ramipril—type 1 diabetes mellitus	0.0111	0.0174	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—AIF1—type 1 diabetes mellitus	0.01	0.0291	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Ramipril—type 1 diabetes mellitus	0.00988	0.0155	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00955	0.015	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—type 1 diabetes mellitus	0.0094	0.0273	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CRP—type 1 diabetes mellitus	0.00936	0.0272	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Ramipril—type 1 diabetes mellitus	0.00923	0.0145	CcSEcCtD
Trisalicylate-choline—Vomiting—Ramipril—type 1 diabetes mellitus	0.00888	0.014	CcSEcCtD
Trisalicylate-choline—Rash—Ramipril—type 1 diabetes mellitus	0.0088	0.0138	CcSEcCtD
Trisalicylate-choline—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00879	0.0138	CcSEcCtD
Trisalicylate-choline—Headache—Ramipril—type 1 diabetes mellitus	0.00875	0.0138	CcSEcCtD
Trisalicylate-choline—Nausea—Ramipril—type 1 diabetes mellitus	0.00829	0.013	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—type 1 diabetes mellitus	0.00761	0.0221	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CRP—type 1 diabetes mellitus	0.00743	0.0216	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—type 1 diabetes mellitus	0.0063	0.0183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—type 1 diabetes mellitus	0.00613	0.0178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—type 1 diabetes mellitus	0.00586	0.017	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—type 1 diabetes mellitus	0.00562	0.0163	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—HBA1—type 1 diabetes mellitus	0.00525	0.0153	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—type 1 diabetes mellitus	0.00524	0.0152	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PRKCQ—type 1 diabetes mellitus	0.00491	0.0143	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.00438	0.0127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1R1—type 1 diabetes mellitus	0.00435	0.0126	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—TNF—type 1 diabetes mellitus	0.00424	0.0123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.00421	0.0122	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—HBA1—type 1 diabetes mellitus	0.00417	0.0121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—type 1 diabetes mellitus	0.00416	0.0121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—type 1 diabetes mellitus	0.00407	0.0118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—type 1 diabetes mellitus	0.00396	0.0115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—E2F1—type 1 diabetes mellitus	0.00394	0.0115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—type 1 diabetes mellitus	0.00379	0.011	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—type 1 diabetes mellitus	0.0037	0.0108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—LGALS3—type 1 diabetes mellitus	0.00367	0.0107	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—type 1 diabetes mellitus	0.00363	0.0106	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	0.00346	0.01	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—IL6—type 1 diabetes mellitus	0.00342	0.00994	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—TNF—type 1 diabetes mellitus	0.00336	0.00977	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—type 1 diabetes mellitus	0.00329	0.00957	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	0.00328	0.00953	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—type 1 diabetes mellitus	0.00321	0.00934	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.003	0.00872	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.00296	0.0086	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	0.00275	0.00798	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	0.00275	0.00798	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—IL6—type 1 diabetes mellitus	0.00271	0.00789	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS1—type 1 diabetes mellitus	0.00264	0.00766	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	0.0026	0.00756	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—type 1 diabetes mellitus	0.0024	0.00696	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL10—type 1 diabetes mellitus	0.00239	0.00695	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.0023	0.00667	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00223	0.00648	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	0.00218	0.00633	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—type 1 diabetes mellitus	0.00213	0.0062	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—type 1 diabetes mellitus	0.00213	0.00619	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.0021	0.00612	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL4—type 1 diabetes mellitus	0.00199	0.0058	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—E2F1—type 1 diabetes mellitus	0.00198	0.00576	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.00192	0.00558	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.00182	0.0053	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.00174	0.00506	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.00171	0.00498	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.00167	0.00485	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.00166	0.00482	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDK4—type 1 diabetes mellitus	0.00162	0.0047	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS2—type 1 diabetes mellitus	0.00157	0.00457	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—type 1 diabetes mellitus	0.00155	0.00451	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CD4—type 1 diabetes mellitus	0.00153	0.00444	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.00152	0.00443	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.00136	0.00395	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00135	0.00392	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.0013	0.00377	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.00124	0.00361	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IFNG—type 1 diabetes mellitus	0.00121	0.0035	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00117	0.00341	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.0011	0.0032	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—type 1 diabetes mellitus	0.00108	0.00312	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CASP3—type 1 diabetes mellitus	0.00107	0.00312	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL2—type 1 diabetes mellitus	0.00107	0.00311	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HBA2—type 1 diabetes mellitus	0.00103	0.00298	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.001	0.00291	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.000987	0.00287	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000965	0.0028	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000948	0.00276	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000931	0.00271	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—G6PC2—type 1 diabetes mellitus	0.000915	0.00266	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000837	0.00243	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	0.000819	0.00238	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HBA2—type 1 diabetes mellitus	0.000815	0.00237	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.000796	0.00231	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—type 1 diabetes mellitus	0.00078	0.00227	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000766	0.00223	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.00073	0.00212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000664	0.00193	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000661	0.00192	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	0.00063	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000558	0.00162	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000557	0.00162	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	0.000554	0.00161	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000531	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	0.000529	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	0.000526	0.00153	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000525	0.00153	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	0.000522	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000513	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IAPP—type 1 diabetes mellitus	0.000495	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOC3—type 1 diabetes mellitus	0.000495	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—B2M—type 1 diabetes mellitus	0.000475	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000473	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000443	0.00129	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	0.000417	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	0.000415	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	0.000409	0.00119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000407	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS1—type 1 diabetes mellitus	0.000398	0.00116	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000375	0.00109	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	0.000373	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—VAV1—type 1 diabetes mellitus	0.000362	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	0.000346	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	0.000324	0.000943	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD86—type 1 diabetes mellitus	0.000316	0.000918	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	0.000285	0.000828	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CCR5—type 1 diabetes mellitus	0.00028	0.000814	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	0.000275	0.000798	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	0.000273	0.000793	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS2—type 1 diabetes mellitus	0.000237	0.00069	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD80—type 1 diabetes mellitus	0.00023	0.000669	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—INS—type 1 diabetes mellitus	0.00023	0.000667	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—INS—type 1 diabetes mellitus	0.000218	0.000633	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	0.000211	0.000612	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	0.000201	0.000585	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TYK2—type 1 diabetes mellitus	0.000194	0.000565	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—type 1 diabetes mellitus	0.000191	0.000555	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—INS—type 1 diabetes mellitus	0.000182	0.00053	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD4—type 1 diabetes mellitus	0.000176	0.000511	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	0.000167	0.000486	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	0.00016	0.000465	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—type 1 diabetes mellitus	0.000136	0.000396	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGFR—type 1 diabetes mellitus	0.000124	0.00036	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—type 1 diabetes mellitus	9.51e-05	0.000276	CbGpPWpGaD
